Objectives: Schizophrenia is a chronic mental condition. The objective of this study is to apply time series modelling to Positive and Negative Syndrome Scale scores of outpatients with schizophrenia, observed at regular intervals of time, and hence forecast the number of visits required to reach remission.
| INTRODUCTION
Schizophrenia is a severe chronic mental condition with long-term impairment. Definition of remission in schizophrenia has been a very ambiguous notion. The Remission in Schizophrenia Working Group (RSWG) defined remission as a combination of two components: (a) the symptom severity component or resolution in which eight items selected from the Positive and Negative Syndrome Scale (PANSS) should score 3 or less and (b) the time component that suggests that this score should be maintained for a period of 6 months (Andreasen et al., 2005; Kay, Fizbein, & Opler, 1987) . Assessment of remission in practice raises question regarding time required by a patient to reach either resolution or relapse (Yeomans et al., 2010) . The best predictions arise from statistical methods that fit precise data to valid models describing how the relevant variables contribute to the outcome (McMahon, 2014) .
Time series analysis is a statistical methodology appropriate for prediction in longitudinal research designs involving a single subject or research units that are measured repeatedly at regular intervals of time. There are two main goals of time series analysis: (a) identifying the nature of the phenomenon represented by the sequence of observations (i.e., evaluating the behavioural trend) and (b) forecasting or predicting future values of the behaviour based on the most recent observation (StatSoft, 2004) . Most time series models are defined for stationary time series. However, in practice, most time series are nonstationary in nature. The concept of stationarity of a stochastic process can be visualized as a form of statistical equilibrium (Hipel & McLeod, 1994) .
The most popular and frequently used stochastic time series models are as follows: (a) the autoregressive integrated moving average (ARIMA) model (Box & Jenkins, 1970) and (b) ARIMA with exogenous variable (ARIMAX) model with an added advantage of capturing the influence of independent variable on the dependent variable. This model has the capacity to identify the underlying patterns in time series data and to quantify the impact of environmental influences simultaneously (Victor-Edema & Essi, 2016) . Time series analysis has been used previously for predicting emergency department visits, daily hospital attendance, and admissions, forecasting haemorrhagic fever with renal syndrome incidence, and evaluating patterns of tobacco, alcohol, and marijuana use and disease management (Dierker et al., 2009; Liu, Liu, Jiang, & Yang, 2011; Rathlev et al., 2007; Sato, 2013; Soyiri & Reidpath, 2012; Sun, Heng, Seow, & Seow, 2009 ). Moore, Little, McSharry, Geddes, and Goodwin (2012) used time series analysis to forecast depression in patients with bipolar disorder. Walther, Ramseyer, Horn, Strik, and Tschacher (2013) In this study, the threshold for resolution or symptom severity criteria of remission is assumed to be a total score of PANSS less than or equal to 45 (indicating "very mild" category by Levine, Rabinowitz, Engel, Etschel, & Leucht, 2008) from the perspective of forecasting.
The data consisted of two categories of patients: (a) who had achieved remission by the end of study period (i.e. total PANSS score less than or equal to 45 and a score less than or equal to 3 for selected eight items of PANSS as given by RSWG; Andreasen et al., 2005) and (b) who had not achieved remission by the end of study period. The data of patients belonging to the first category are used for model selection only as forecasting is not required for them. For patients belonging to the second category, we forecasted number of visits required to achieve remission on the basis of PANSS scores using selected models. Finally, the performance of ARIMA and ARIMAX models is compared on the basis of mean absolute percentage error (MAPE) and mean absolute deviation (MAD) of the fitted models. The accuracy of forecasts derived from two models is also compared using DieboldMariano (DM) test (Diebold & Mariano, 1995) .
The outline of the rest of the paper is as follows: In Section 2, data and methodology used have been discussed. Section 3 describes the application of time series analysis to the data along with the results obtained. The paper is concluded with a discussion in Section 4. duration of illness, and course and onset of illness, and scores on psychiatric rating scales, namely, PANSS (Kay et al., 1987) , Brief Psychiatric Rating Scale (Overall & Gorham, 1962) , CGI-S scale, Clinical Global Impression-Improvement scale (Guy, 1976b ), Simpson-Angus Rating Scale (Simpson & Angus, 1970) , Montgomery-Åsberg Depression Rating Scale (Montgomery & Asberg, 1979) , Behavioural Activation for Depression Scale (Kanter, Mulick, Busch, Berlin, & Martell, 2007) , and Abnormal Involuntary Movement Scale (Guy, 1976a) , as recorded by psychiatrists were available. The patients were receiving antipsychotic medications. Out of 14 patients, four patients could not achieve remission at the end of 18 months. It was observed that the remaining 10 patients who achieved remission had minimal severity of symptoms, that is, had scored 3 or less on the eight items of PANSS as given by RSWG and also maintained the same for a duration of 6 months. The mean and standard deviation of age and duration of illness of patients were found to be (30 years, 5.6140) and (9.5 years, 4.2083), respectively. The descriptive statistics of PANSS and CGI-S scale of patients are given in Table 1 . 
where φ k,i (i = 1, 2, …, p) and θ k,j (j = 1, 2, …, q) are model parameters of autoregressive and moving average part of the model with ε k,t being error terms for k th patient at visit t (t = 1, 2, …, 21) and μ is a constant.
Equation (1) can also be written as
and L is the lag operator.
The random errors, ε k,t are assumed to be a white noise process (Box & Jenkins, 1970) , that is, a sequence of independent and identically distributed random variables sampled from a normal distribution with zero mean and a constant variance. If the time series is not stationary (i.e. mean and variance of the series are not constant), it is transformed into stationary series by applying appropriate differencing scheme. If d is the order of differencing, the resulting stationary series y k,t may be represented by an ARIMA (p, d, q) model as (Box & Jenkins, 1970 )
where (p, d, q) refer to the order of the model. p is the order (number of time lags) of the autoregressive model, d is the degree of differencing, and q is the order of the moving average model.
| ARIMAX model
The ARIMA model can be extended to ARIMAX model by incorporating an explanatory variable X. In this study, CGI-S scale score for a patient is assumed to be the independent variable. Let x k,t represent the CGI-S scale score for k th patient (k = 1,2,…, 14) at visit
where β k are coefficients of x k,t and (p, d, q) are as defined in ARIMA model.
| Augmented Dickey-Fuller test for stationarity
The augmented Dickey-Fuller (ADF) test is used to check the stationarity of a time series. The regression model employed by Dickey and Fuller (1979) is given by
where Δy t,k = y t,k − y k,(t − 1) , α is a constant, λ k,t is the coefficient of time trend, p is the lag order of the autoregressive process, and ε k,t is the error term for k th patient. The ADF test statistic is given by
where SE b δ k is the standard error of the least squares estimate of δ k , to test the null hypothesis (the time series contains a unit root, i.e.
δ k = 0) against the hypothesis that the time series is stationary. The ADF test statistic follows t distribution.
| Ljung-Box test for autocorrelation
It is a prerequisite for the transformed series to not exhibit significant autocorrelation for applying ARIMA/ARIMAX models. The significance of the autocorrelation of the transformed time series is tested using Ljung-Box test (Ljung & Box, 1978) . Under this test, the null hypothesis (the autocorrelation at lag h is zero, i.e. ρ k, h = 0) is tested against the hypothesis that the autocorrelation at lag h is nonzero, that is, ρ k, h ≠ 0, and the test statistic is given by
where n is the number of usable data points after differencing operation, b ρ k;h is the sample autocorrelation at lag h, and m is the number of lags being tested for kth patient. The statistic Q k follows a χ 2 m distribution.
| Granger causality test
Granger causality test is used to verify the significance of the causal relationship of the exogenous variable (CGI-S scale) with the dependent variable (PANSS) prior to application of ARIMAX model (Granger, 1969) . Consider the equation
where α is a constant, β k,l is coefficient of (t − l) th lagged value of x variable (CGI-S scale) for k th patient, and φ k,i , y k,(t − i) and ε k,t are as defined in Section 2.2.1. The null and alternative hypotheses are given as follows:
Null hypothesis:
The test statistic is given by
where SSR r is restricted sum of squared residuals obtained by regressing y k,t on its past values excluding x k,t whereas SSR u is unrestricted sum of squared residuals obtained by regressing y k,t on its past values and lagged values of x k,t and T is the total number of observations. The statistic F k follows F n, (T − (p + n + 1)) distribution.
| DM test for comparing accuracy of forecasts
This test is used for comparing the accuracy of forecasts derived from two models. Let b y k;t;arima and b y k;t;arimax denote forecasts of the time series y k,t of k th patient at visit t (t = 1, 2, …, T) by ARIMA and ARIMAX models. Let the associated forecast errors be ε k,t,arima and ε k,t,arimax . Denote the loss functions associated with forecast errors ε k,t,arima and ε k,t,arimax as g(ε k,t,arima ) and g(ε k,t,arimax ), respectively. The loss differential between the two forecasts for k th patient is 
where
t is the sample mean loss differential and b σ dk is a consistent estimate of the standard deviation of d k .
| Procedure for application of ARIMA/ARIMAX models
The procedure followed to apply ARIMA and ARIMAX models is described as follows:
• Check stationarity of time series.
• Obtain value of d component of ARIMA/ARIMAX model for nonstationary series.
• Inspect causal influence of exogenous variable (CGI-S scale) on dependent variable (PANSS)-applicable for ARIMAX model only.
• Test significance of autocorrelation of time series.
• Determine the components p and q of model using autocorrelation function (ACF) and partial autocorrelation function (PACF).
• Fit the candidate models.
• Select a model using Akaike information criteria (AIC) and Bayesian Information Criterion (BIC).
• Test autocorrelation of residuals for significance.
• Assess normality and homoscedasticity of residuals.
• Compare ARIMA and ARIMAX models.
• Forecast number of visits required to reach remission using selected model.
| RESULTS
In this study, the total scores of PANSS measured at 21 visits for all 14 patients are treated as separate time series and are denoted as PANSS1 for the first patient with patient code PAT01, PANSS2 for the second patient with patient code PAT02, …, and PANSS14 for the 14th patient with patient code PAT14. The PANSS total score plot for PAT02 with respect to 21 visits to OPD is shown in Figure 1 .
There is a consistent downward trend over the visits. A time series with a trend is nonstationary in nature. The process of model selection and forecasting is demonstrated stepwise as discussed in Section 2.7
using PANSS scores of a single patient PAT02, whereas results are presented for all 14 patients.
Step 1 Stationarity: Stationarity of time series is tested using ADF test (Dickey & Fuller, 1979) . The value of ADF statistic and corresponding p value for PAT02 (PANSS score) are found to be −1.0869 and 0.9078, which does not support the rejection of the null hypothesis of nonstationarity. Next, a finite differencing of order 1 is applied to this series. We failed to reject the null hypothesis again on this series using ADF test. Further, we observed that this time series FIGURE 1 Time series plot of PANSS scores with respect to 21 visits for PAT02. PAT02 refers to the code for the second patient. PANSS2 is the time series of total scores of PANSS measured at 21 visits for PAT02. PANSS: Positive and Negative Syndrome Scale FIGURE 2 Time series plot of PANSS scores with respect to 21 visits for the second patient PAT02 after differencing twice. PAT02 refers to the code for the second patient. DPANSS2 represents the transformed time series of total scores of PANSS measured at 21 visits for PAT02 after applying differencing of order 2. PANSS: Positive and Negative Syndrome Scale is found to be stationary on applying a finite difference of order 2.
The transformed series is represented as DPANSS2 for PAT02. From Figure 2 , it is obvious that the trend component present in nonstationary series has been removed by differencing. The series appears to be more stabilized as compared with Figure 1 . Similar procedure was followed for PANSS scores of all 14 patients, and series were found to be stationary after applying differencing of order 2.
Thus, the d component for both ARIMA and ARIMAX models is observed to be 2 for all patients. represented as DPANSS1 for PAT01, DPANSS2 for PAT02, …, and DPANSS14 for PAT14. It can be seen from Table 2 that series are stationary at 5% level of significance corresponding to all patients.
Step 2 Checking causality (applicable to ARIMAX model only): The causal influence of the exogenous variable (CGI-S scale) with the dependent variable (PANSS) is checked using Granger causality test (Granger, 1969) . For PAT02, the test resulted in a highly significant p value of 0.0020 concluding that the null hypothesis of no Granger causality is rejected. Likewise, Granger causality test is verified for all patients, and results obtained were found to be congruent with this result.
Step 3 Autocorrelation check: The Ljung-Box test is employed to test the significance of the autocorrelation of the transformed time series DPANSS2 (Ljung & Box, 1978) . As the p value was less than 0.05, it can be concluded that the null hypothesis is rejected indicating that AR and/or MA terms must be added into the model to remove the serial correlation. The same results were observed for all the patients. The ACF and PACF values up to Lag 6 for all patients are summarized in Table 3 . Step 4a 
Similar procedure was performed for all patients resulting in ARIMA (1, 2, 1) as the final model. The significance of coefficients of AR1 and MA1 terms of ARIMA
(1, 2, 1) model is tested using z test and is found to be highly significant (p value < 0.05) for all patients.
Step 4b 
Similarly, ARIMAX (1, 2, 1) model with CGI-S scale score as exogenous variable is fitted to all patients' data. The significance of coefficients of AR1, MA1, and x variables of ARIMAX (1, 2, 1) model is tested using z test and is found to be highly significant (p value < 0.05) for all patients.
Step 5 and ARIMAX (1, 2, 1) models. The results provided little evidence that autocorrelation remained in the residuals. Thus, ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models appeared to be strong. Table 6 summarizes the Ljung-Box statistic and p value for residuals from ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models. Hence, our model has captured all the structure of the time series for PAT02. Similar results were observed for all patients with both ARIMA and ARIMAX models.
Step 6 Normality and homoscedasticity check of residuals: In addition to testing for independence of the residuals, the assumptions of normality and homoscedasticity of residuals are also validated using Kolmogorov-Smirnov (K-S) and White's tests (Massey, 1951; White, 1980) . The K-S test statistic value for the residuals from ARIMA (1, 2, 1) model for PAT02 is calculated to be 0.095 with a p value of 0.982, which does not support rejection of the null hypothesis of normally distributed residuals. This can also be verified from the normal Q-Q plot of standardized residuals shown in Figure 4 . Similarly, the residuals estimated from both ARIMA and ARIMAX models for all patients were found to be normally distributed using K-S test. The significance of heteroscedasticity among residuals was assessed for all patients for both ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models using White's test. The results indicated that the residuals do not exhibit heteroscedasticity at 0.05 level for all patients.
Step 7 Comparison between ARIMA and ARIMAX models: In this study, ARIMA and ARIMAX models are compared in four ways. First, their fit performance is compared by plotting the fitted ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models against actual data. Second, they are compared in terms of MAPE and MAD produced by them. Third, the AIC values derived from fitted models are compared, and lastly, the accuracy of forecasts derived from two models is compared using DM test (Diebold & Mariano, 1995) . (1, 2, 1) models are presented in Table 7 . From Table 7 , it is observed that the ARIMAX ( Step 8 Forecasting: Finally, we forecasted the number of visits required to reach resolution (first step of remission) for the outpatients, who did not achieve remission by the end of study. We predicted the PANSS scores with ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models for the next visits until the symptom severity becomes "very mild" (i.e., the PANSS score becomes less than or equal to 45; Levine et al., 2008) . The CGI-S scale scores supplied for forecasting are based on the relationship between PANSS and CGI-S scale as described in the study (Levine et al., 2008) . Table 8 presents PANSS scores and number of visits forecasted from fitted ARIMA (1, 2, 1) and ARIMAX (1, 2, 1) models with CGI-S scale scores of patients as exogenous variable.
All calculations were performed in R version 3.4.0. (Yeomans et al., 2010) . Time to remission is the time to resolution with an added duration of 6 months during which the minimal severity of symptoms is maintained with respect to the definition of remission given by RSWG (Andreasen et al., 2005) . Forecasting can be used to predict the time required by a patient to achieve resolution.
Time series analysis is a very useful tool to forecast number of visits required to achieve remission on the basis of the remission criteria whenever data of outpatients are recorded at regular intervals of time irrespective of the disease. ARIMA and ARIMAX models are important and widely used models because they provide a basic methodology to model the effects of dependency from the data series and allow valid statistical testing (Velicer & Fava, 2003) .
In this paper, first, we have used ARIMA model to forecast the number of visits required to reach resolution (first step of remission)
for the outpatients who did not achieve remission by the end of study on the basis of the PANSS scores. The criterion used for remission is a total score of PANSS less than or equal to 45 (belonging to "very mild" category by Levine et al., 2008) along with a score less than or equal to 3 for selected eight items of PANSS as given by RSWG (Andreasen et al., 2005) . Second, a similar procedure of forecasting is performed with ARIMAX model with CGI-S scale as exogenous variable. We have used CGI-S scale as independent variable as previous studies suggest that it is possible to extrapolate from a CGI-S scale to a PANSS severity score (Levine et al., 2008) .
The PANSS and CGI-S scale are used together to measure severity of psychotic illness, and the CGI-S scale shows overlap with the core symptoms of schizophrenia. Previous studies found them to be correlated but not synonymous (Rabinowitz, Mehnert, & Eerdekens, 2006) .
We observed that ARIMAX model performed better than ARIMA model (which is in accordance with a previous study ; Taweesin, Seeboonruang, & Saraphirom, 2018) in terms of MAPE, MAD, and AIC values of the fitted models, whereas according to DM test (Diebold & Mariano, 1995) , the accuracy of the two models was found to be similar for some cases. We suggest to prefer ARIMAX model over ARIMA whenever information on exogenous variable can be supplied as additional information results in a better model.
Forecasting is also beneficial in regulating the treatment adherence by a patient. This study will not only facilitate the clinicians in efficient prognosis by projecting an approximate time to symptom remission for the patient but also assist them in management of appropriate interventions and resources. Further, it has an implication of instilling hope in patients and their families as a major step towards recovery.
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